Unitus Seed Fund's investees touch 1.2 million lives in India
The social impact investment firm's first fund, of $23 million, helped 14 investee startups create real jobs, find financial stability and expand the ecosystem

Image: Shutterstock
With its investments in the 14 startups in its active portfolio, Unitus Seed Fund, a leading social impact investment firm, has improved the lives of over 1.2 million people at the bottom of the pyramid (BoP).
“The one million landmark is significant for the entire investing ecosystem: We’ve now shown the scale of impact a seed-level fund can achieve in a short span of four-and-a-half years,” Poole writes in the report.
The report also says that Unitus has aligned its outcomes with some of the Sustainable Development Goals (SDGs) laid down by the United Nations (UN), calling it a “first-of-its-kind move within the Indian investment ecosystem”.
Aligning with UN goals means that investors get a standardised framework for any participant—donors, traditional or impact investors, non-profits, philanthropists and social-impact businesses—to track cumulative progress against targets. That, in turn, makes it easier to channelise money to meet the twin objectives of maximum impact and market-rate financial returns.Work done by Unitus’s portfolio companies focuses on four of the 17 SDGs: Ending poverty, ensuring healthy lives and promoting well-being, ensuring quality education for all, and promoting decent work and economic growth. Unitus’s fund has invested in startups in the education, health care, financial technology, retail and e-commerce, mobile, consumer internet and agriculture sectors.
Among the companies are grassroots interventions such as Hippocampus Learning Centres, which has recruited and trained local teachers to impart formal kindergarten education in villages, and mobile internet-based services such as DriveU, a driver-on-demand business for people who’d rather be driven in their own cars.
Unitus has also backed hi-tech innovation in health care, with ventures such as UE LifeSciences, which is commercialising a highly portable non-invasive breast scan device to help detect signs of breast cancer. UE LifeSciences has also won the backing of Kiran Mazumdar-Shaw, founder of biopharma company Biocon.
The firm is currently raising its second fund of $50 million and plans to back between 25 and 30 startups in education, health care and financial technology by 2021.
First Published: Nov 16, 2017, 06:53
Subscribe Now